Quiver Bioscience

Cambridge, MA · Founded 2013 · Privately Held (backing)

Developer of a neuroscience research platform designed to accelerate the discovery of therapeutics for central nervous system disorders. Quiver Bioscience is based in Cambridge, MA and was founded in 2013. Its last reported valuation was $29 million in Nov 2018. It has raised $54.4 million.

Last reported valuation
$29.0M
Oct 2026
Priced at
—
Total raised
$54.4M
Last round
—

Who backs Quiver Bioscience?

4 investors
InvestorType
Pimlico Pond InvestmentsFamily office
Exponential Capital (Atlanta)—
National Institutes of Neurological Disorders and Stroke—
Porta (Beverages)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Quiver Bioscience investors

4 investors are on record for Quiver Bioscience, including Pimlico Pond Investments, Exponential Capital (Atlanta), National Institutes of Neurological Disorders and Stroke and Porta (Beverages).

Free account
More of Quiver Bioscience with a free account
  • ·Watch Quiver Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Quiver Bioscience. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View